Pharmacological Classification

Sildenafil Drug Class

Sildenafil belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, a group of medications that act on the nitric oxide–cGMP pathway to influence vascular smooth muscle relaxation.

What Is the Drug Class?

Sildenafil is classified as a phosphodiesterase type 5 (PDE5) inhibitor. This class of drugs is designed to inhibit the PDE5 enzyme, which plays a role in the breakdown of cyclic guanosine monophosphate (cGMP).

By preventing cGMP degradation, PDE5 inhibitors enhance vasodilation in specific vascular tissues, particularly those involved in smooth muscle relaxation.

PDE5 Inhibitor Class Characteristics

  • Selective inhibition of PDE5 enzyme activity
  • Enhancement of nitric oxide (NO) signaling pathway
  • Increased cGMP levels in smooth muscle tissue
  • Vasodilation in targeted vascular beds

This class is defined by its mechanism-based action rather than chemical structure alone.

Medications in the Same Class

  • Sildenafil
  • Tadalafil
  • Vardenafil
  • Avanafil
  • Udenafil

All these compounds share the same PDE5 inhibition mechanism but differ in pharmacokinetics, duration of action, and selectivity profiles.

Class-Based Differences

  • Onset time: varies across molecules
  • Duration: short-acting vs long-acting PDE5 inhibitors
  • Selectivity: minor differences in enzyme affinity
  • Metabolism: liver enzyme pathways differ between compounds

Clinical Classification Context

PDE5 inhibitors are part of a broader group of vasomodulating agents that influence vascular tone through intracellular signaling pathways rather than direct receptor activation.

Related Pages

Hub
Sildenafil

Main sildenafil hub page.
Medication
Sildenafil Mechanism

General MOA overview.
Uses
Sildenafil Uses

Use-case and application pages.

FAQ

Sildenafil belongs to the phosphodiesterase type 5 inhibitor class, commonly abbreviated as PDE5 inhibitor. This class includes several related pharmaceutical compounds.

PDE5 inhibitor refers to a group of pharmaceutical compounds that interact with the phosphodiesterase type 5 enzyme pathway. Sildenafil is one of the best-known compounds in this category.

Yes. Sildenafil belongs to a broader PDE5 inhibitor group that includes other compounds such as tadalafil, vardenafil, avanafil, and udenafil.

Viagra is a branded product that contains sildenafil as its active ingredient. Because of this, Viagra belongs to the same PDE5 inhibitor drug class.

No. Both branded and generic sildenafil products belong to the same pharmacological class because they contain the same active compound.

Yes. Different sildenafil formulations such as tablets and oral jelly remain part of the same PDE5 inhibitor category because the active ingredient is unchanged.

Drug class information helps organize pharmaceutical compounds into related categories based on shared pharmacological characteristics and mechanism-related properties.

Additional sildenafil classification information is available through related pages covering sildenafil mechanism, uses, branded products, dosage references, and comparison resources.